Pancreatic Cancer Research

ResearcherCedars-Sinai Medical CenterNo recent work listed

Yun Zheng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6717-3959; OpenAlex author ID A5081641076. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 3

  1. Long-term effects of total vs. partial pancreatectomy among patients with pancreatic cancer: a population-based study. Last author DOI 10.21037/atm-22-2217↗
  2. Functional Genome-wide Screening Identifies Targets and Pathways Sensitizing Pancreatic Cancer Cells to Dasatinib. Co-author DOI 10.7150/jca.25138↗
  3. Growth inhibition of pancreatic cancer cells by histone deacetylase inhibitor belinostat through suppression of multiple pathways including HIF, NFkB, and mTOR… Co-author DOI 10.1002/mc.22024↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Andreas Minh Luu · 1 shared paper, 2022 · strength 0.13
  2. Zhiwen Yang · 1 shared paper, 2022 · strength 0.13
  3. Qiang Tao · 1 shared paper, 2022 · strength 0.13
  4. Lingmin Jiang · 1 shared paper, 2022 · strength 0.13
  5. Yong Wang · 1 shared paper, 2022 · strength 0.13
  6. Wenwen Chien · 2 shared papers, 2014–2018 · strength 0.10
  7. Harold Phillip Koeffler · 2 shared papers, 2014–2018 · strength 0.10
  8. Manoj Garg · 1 shared paper, 2018 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.